To meet our biotech and pharmaceutical partners’ needs, GnomeSciences has quadrupled the size of our lab services team brought online additional research services. GnomeSciences’ capabilities now span molecular biology, anatomical and histo-pathology, molecular pathology and digital pathology, as well as multicolor immunohistochemistry, in situ hybridization, ELISA, gene variant and gene expression analysis, and assay development and validation. As examples, our Diagnostics division implemented a laboratory developed test (LDT) for SARS-CoV-2 RT-PCR for patient screening and our board-certified pathologist and medical director published key papers on cellular and molecular mechanisms of action in fatal COVID-19 cases.